Search Results
You are looking at 1 - 7 of 7 items for
- Author: Licio A Velloso x
- Refine by access: All content x
Search for other papers by Raquel Barbuio in
Google Scholar
PubMed
Search for other papers by Marciane Milanski in
Google Scholar
PubMed
Search for other papers by Manoel B Bertolo in
Google Scholar
PubMed
Search for other papers by Mário J Saad in
Google Scholar
PubMed
Search for other papers by Lício A Velloso in
Google Scholar
PubMed
Non-alcoholic fatty liver disease, induced by nutritional factors, is one of the leading causes of hepatic dysfunction in the modern world. The activation of proinflammatory signaling in the liver, which is induced by systemic and locally produced cytokines, and the development of hepatic insulin resistance are two important factors associated with the progression from steatosis to steatohepatitis, a pre-cirrhotic condition. The objective of the present study was to evaluate the effect of inhibition of tumour necrosis factor (TNF)-α , using the monoclonal antibody infliximab, on the expression of cytokines, induction of steatosis and fibrosis, and insulin signal transduction in the liver of Wistar rats fed a high-fat diet. Ten days of treatment with infliximab significantly reduced the expression of the proinflammatory markers, TNF-α , IL-6, IL-1β , and SOCS-3, in the liver of rats fed a high-fat diet. This was accompanied by reduced fat deposition and fibrosis and by improved insulin signal transduction through insulin receptor (IR)/IR substrate/Akt/FOXO1 and JAK2/STAT3 pathways. In conclusion, short-term inhibition of TNF-α with infliximab reduces inflammation and steatosis/fibrosis, while improving insulin signal transduction in an animal model treated with a high-fat diet.
Search for other papers by Andréa M Caricilli in
Google Scholar
PubMed
Search for other papers by Paula H Nascimento in
Google Scholar
PubMed
Search for other papers by José R Pauli in
Google Scholar
PubMed
Search for other papers by Daniela M L Tsukumo in
Google Scholar
PubMed
Search for other papers by Lício A Velloso in
Google Scholar
PubMed
Search for other papers by José B Carvalheira in
Google Scholar
PubMed
Search for other papers by Mário J A Saad in
Google Scholar
PubMed
The aims of the present study were to investigate the expression of toll-like receptor 2 (TLR2) in muscle and white adipose tissue (WAT) of diet-induced obesity (DIO) mice, and also the effects of its inhibition, with the use of TLR2 antisense oligonucleotide (ASON), on insulin sensitivity and signaling. The expression of TLR2 was increased in muscle and WAT of DIO mice, compared with those that received standard chow. Inhibition of TLR2 in DIO mice, by TLR2 ASON, improved insulin sensitivity and signaling in muscle and WAT. In addition, data show that the inhibition of TLR2 expression prevents the activation of IKBKB, MAPK8, and serine phosphorylation of IRS1 in DIO mice, suggesting that TLR2 is a key modulator of the crosstalk between inflammatory and metabolic pathways. We, therefore, suggest that a selective interference with TLR2 presents an attractive opportunity for the treatment of insulin resistance in obesity and type 2 diabetes.
Search for other papers by Márcio Pereira-da-Silva in
Google Scholar
PubMed
Search for other papers by Cláudio T De Souza in
Google Scholar
PubMed
Search for other papers by Alessandra L Gasparetti in
Google Scholar
PubMed
Search for other papers by Mário J A Saad in
Google Scholar
PubMed
Search for other papers by Lício A Velloso in
Google Scholar
PubMed
Transgenic hyperexpression of melanin-concentrating hormone (MCH) produces a phenotype of obesity and glucose intolerance. However, it is not known whether under this specific condition, glucose intolerance develops as a direct consequence of hyperexpressed MCH or is secondary to increased adiposity. Here, rats were treated i.c.v. with MCH or with an antisense oligonucleotide to MCH (MCH-ASO). MCH promoted an increase in blood glucose and a decrease in blood insulin levels during a glucose tolerance test. MCH also caused a decrease in the constant of glucose disappearance during an insulin tolerance test. All these effects of MCH were independent of body weight variation and were accompanied by reduced insulin receptor substrate (IRS)-1 engagement of phosphatidylinositol-3 kinase (PI3-kinase) in white and brown adipose tissues, skeletal muscle and liver and by reduced Akt activation in skeletal muscle. MCH also led to a significant reduction in ERK activation in white adipose tissue. Finally, inhibition of hypothalamic MCH expression promoted a significant increase in ERK activation in brown adipose tissue. We conclude that hypothalamic MCH controls glucose homeostasis through mechanisms that are, at least in part, independent of adiposity.
Search for other papers by Daniela F Bertelli in
Google Scholar
PubMed
Search for other papers by Andressa Coope in
Google Scholar
PubMed
Search for other papers by Andrea M Caricilli in
Google Scholar
PubMed
Search for other papers by Patricia O Prada in
Google Scholar
PubMed
Search for other papers by Mario J Saad in
Google Scholar
PubMed
Laboratory of Cell Signaling, Department of Internal Medicine, Department of Nursing
Search for other papers by Licio A Velloso in
Google Scholar
PubMed
Laboratory of Cell Signaling, Department of Internal Medicine, Department of Nursing
Search for other papers by Eliana P Araujo in
Google Scholar
PubMed
The 72 kDa inositol polyphosphate 5-phosphatase E (72k-5ptase) controls signal transduction through the catalytic dephosphorylation of the 5-position of membrane-bound phosphoinositides. The reduction of 72k-5ptase expression in the hypothalamus results in improved hypothalamic insulin signal transduction and reduction of food intake and body mass. Here, we evaluated the tissue distribution and the impact of obesity on the expression of 72k-5ptase in peripheral tissues of experimental animals. In addition, insulin signal transduction and action were determined in an animal model of obesity and insulin resistance treated with an antisense (AS) oligonucleotide that reduces 72k-5ptase expression. In lean Wistar rats, 72k-5ptase mRNA and protein are found in highest levels in heart, skeletal muscle, and white adipose tissue. In three distinct models of obesity, Wistar rats, Swiss mice fed on high-fat diet, and leptin-deficient ob/ob mice, the expression of 72k-5ptase is increased in skeletal muscle and adipose tissue. The treatment of obese Wistar rats with an anti-72k-5ptase AS oligonucleotide results in significant reduction of 72k-5ptase catalytic activity, which is accompanied by reduced food intake and body mass and improved insulin signal transduction and action as determined by immunoblotting and clamp studies respectively. 72k-5ptase expression is increased in obesity and its AS inhibition resulted in a significant improvement in insulin signal transduction and restoration of glucose homeostasis.
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by Cid Pitombo in
Google Scholar
PubMed
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by Eliana P Araújo in
Google Scholar
PubMed
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by Cláudio T De Souza in
Google Scholar
PubMed
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by José C Pareja in
Google Scholar
PubMed
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by Bruno Geloneze in
Google Scholar
PubMed
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by Lício A Velloso in
Google Scholar
PubMed
The effect of visceral fat removal upon glucose homeostasis, insulin signal transduction, and serum adipokine levels in an animal model of diet-induced obesity and diabetes mellitus (DIO) was evaluated. Swiss mice were initially divided into two groups fed with regular rodent chow or with chow containing 24 g% saturated fat (DIO). DIO mice became obese and overtly diabetic after 8 weeks. DIO mice were then divided into three groups: control, sham, and visceral (epididymal and perinephric) fat removal. All groups were submitted to evaluation of basal glucose and insulin levels and i.p. insulin tolerance test. Insulin signal transduction in muscle was evaluated by immunoprecipitation and immunoblot, and serum adipokine levels were determined by ELISA. DIO mice became diabetic (228 versus 115 mg/dl), hyperinulinemic (7.59 versus 3.15 ng/ml) and insulin resistant (K itt 2.88 versus 4.97%/min) as compared with control. Visceral fat removal partially reverted all parameters (147 mg/dl glucose; 3.82 ng/ml insulin; and 4.20%/min K itt ). In addition, visceral fat removal completely reversed the impairment of insulin signal transduction through insulin receptor, insulin receptor substrate (IRS)-1, IRS-2 and Akt in muscle. Finally, serum levels of the pro-inflammatory cytokines tumour necrosis factor-α, interleukin (IL)-1β and IL-6 were significantly increased, while adiponectin levels were significantly reduced in DIO mice. After visceral fat removal the levels of adipokines returned to near control levels. The present study shows that removal of visceral fat improves insulin signal transduction and glucose homeostasis in an animal model of diet-induced obesity and diabetes mellitus and these metabolic and molecular outcomes are accompanied by the restoration of adipokine levels.
Search for other papers by Graziela R Stoppa in
Google Scholar
PubMed
Search for other papers by Maristela Cesquini in
Google Scholar
PubMed
Search for other papers by Erika A Roman in
Google Scholar
PubMed
Search for other papers by Patrícia O Prada in
Google Scholar
PubMed
Search for other papers by Adriana S Torsoni in
Google Scholar
PubMed
Search for other papers by Talita Romanatto in
Google Scholar
PubMed
Search for other papers by Mario J Saad in
Google Scholar
PubMed
Search for other papers by Licio A Velloso in
Google Scholar
PubMed
Search for other papers by Marcio A Torsoni in
Google Scholar
PubMed
We hypothesized that citrate might modulate the AMP-activated protein kinase/acetyl-CoA carboxylase (AMPK)/(ACC) pathway and participate in neuronal feeding control and glucose homeostasis. To address this issue, we injected citrate into the lateral ventricle of rats. Intracerebroventricular (ICV) injection of citrate diminished the phosphorylation of hypothalamic AMPK/ACC, increased the expression of anorexigenic neuropeptide (pro-opiomelanocortin and corticotropin-releasing hormone), elevated the level of malonyl-CoA in the hypothalamus, and reduced food intake. No change was observed in the concentration of blood insulin after the injection of citrate. With a euglycemic–hyperinsulinemic clamp, the glucose infusion rate was higher in the citrate group than in the control group (28.6±0.8 vs 19.3±0.2 mU/kg body weight/min respectively), and so was glucose uptake in skeletal muscle and the epididymal fat pad. Concordantly, insulin receptor (IR), IR substrate type 1 (IRS1), IRS2, and protein kinase B (AKT) phosphorylation in adipose tissue and skeletal muscle was improved by citrate ICV treatment. Moreover, the treatment with citrate for 7 days promoted body weight loss and decreased the adipose tissue. Our results suggest that citrate and glucose may serve as signals of energy and nutrient availability to hypothalamic cells.
Search for other papers by Maria E C Amaral in
Google Scholar
PubMed
Search for other papers by Daniel A Cunha in
Google Scholar
PubMed
Search for other papers by Gabriel F Anhê in
Google Scholar
PubMed
Search for other papers by Mirian Ueno in
Google Scholar
PubMed
Search for other papers by Everardo M Carneiro in
Google Scholar
PubMed
Search for other papers by Lício A Velloso in
Google Scholar
PubMed
Search for other papers by Silvana Bordin in
Google Scholar
PubMed
Search for other papers by Antonio C Boschero in
Google Scholar
PubMed
Prolactin (PRL) exerts its biological effects mainly by activating the Janus kinase/signal transducer and activator of transcription 5 (JAK/STAT5) signaling pathway. We have recently demonstrated that PRL also stimulates the insulin receptor substrates/phosphatidylinositol 3-kinase (IRSs/PI3K) and SH2-plekstrin homology domain (SHC)/ERK pathways in islets of neonatal rats. In the present study, we investigated the involvement of the PI3K and MAP kinase (MAPK) cascades in islet development and growth in pregnant rats. The protein expression of AKT1, p70S6K and SHC was higher in islets from pregnant compared with control rats. Higher basal levels of tyrosine phosphorylation were found in classic transducers of insulin cell signaling (IRS1, IRS2 and SHC). Increased levels of threonine/tyrosine phosphorylation of ERK1/2 and serine phosphorylation of AKT and p70S6K were also detected. To assess the participation of PRL in these phenomena, pregnant and control rats were treated with an antisense oligonucleotide to reduce the expression of the PRL receptor (PRLR). Phosphorylation of AKT was reduced in islets from pregnant and control rats, whereas p70S6K protein levels were reduced only in islets from treated pregnant rats. Finally, glucose-induced insulin secretion was reduced in islets from pregnant but not from control rats treated with the PRLR antisense oligonucleotide. In conclusion, downstream proteins of the PI3K (AKT and p70S6K) and MAPK (SHC and ERK1/2) cascades are regulated by PRL signaling in islets from pregnant rats. These findings indicate that these pathways participate in the increase in islet mass and the sensitivity to glucose during pregnancy.
